Renal Research Unit
61 – 80 of 102
- show: 20
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2007
-
Mark
The specific monocarboxylate transporter-1 (MCT-1) inhibitor, AR-C117977, induces donor-specific suppression, reducing acute and chronic allograft rejection in the rat
(
- Contribution to journal › Article
-
Mark
Clinicians underestimate gastrointestinal symptoms and overestimate quality of life in renal transplant recipients: A multinational survey of nephrologists
(
- Contribution to journal › Article
-
Mark
Reduced exposure to calcineurin inhibitors in renal transplantation.
(
- Contribution to journal › Article
-
Mark
Increased prevalence of gastrointestinal symptoms associated with impaired quality of life in renal transplant recipients.
(
- Contribution to journal › Article
-
Mark
Interventional trials involving patients cannot be performed safely without a control group treated with the standard of care.
(
- Contribution to journal › Letter
-
Mark
No robust conclusions to be drawn from clinical trials in the absence of an adequate control group.
(
- Contribution to journal › Letter
-
Mark
The specific monocarboxylate transporter (MCT-1) inhibitor AR-C117977, reduces acute rejection and chronic graft rejection and induces operational tolerance
(
- Contribution to journal › Article
- 2006
-
Mark
Costimulation Blockade-Induced Cardiac Allograft Tolerance: Inhibition of T Cell Expansion and Accumulation of Intragraft cD4+Foxp3+ T Cells.
(
- Contribution to journal › Article
-
Mark
Low incidence of brain death and organ donation in Sweden. Analyses of a six-year prospective registration of all deceased patients in intensive units in Southern Sweden
(
- Contribution to journal › Article
- 2005
-
Mark
Differential expression of tissue factor (TF) in calcineurin inhibitor-induced nephrotoxicity and rejection-implications for development of a possible diagnostic marker.
(
- Contribution to journal › Article
-
Mark
Minimization of immunosuppressive therapy after renal transplantation: Results of a randomized controlled trial
(
- Contribution to journal › Article
-
Mark
Sverige har potential för organdonation. Analys av fem års heltäckande registrering av IVA-dödsfall i södra Sverige
(
- Contribution to journal › Article
- 2004
-
Mark
Additive effects of leflunomide and tacrolimus in prevention of islet xenograft rejection
(
- Contribution to journal › Article
-
Mark
Renal replacement therapy in Sweden
(
- Contribution to journal › Article
- 2003
-
Mark
Tailoring of minimal immunosuppression long term.
(
- Contribution to journal › Article
-
Mark
Linomide and antibody-targeted superantigen therapy abolishes formation of liver metastases in mice.
(
- Contribution to journal › Article
-
Mark
Graft survival benefit to be expected of new immunosuppressive regimens
(
- Contribution to journal › Article
-
Mark
Medical-record review of potential donor pool in the Czech Republic suggests a possible increase to more than double the number of donors
(
- Contribution to journal › Article
-
Mark
Minimizing immunosuppression after renal transplantation
(
- Chapter in Book/Report/Conference proceeding › Paper in conference proceeding
-
Mark
Two doses of daclizumab in conjunction with low-dose cyclosporine, mycophenolate mofetil and steroids resulted in a low incidence of acute rejection after renal transplantation.
(
- Contribution to journal › Article